USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
10 Nov 2021 | 03:45 PM GMT

Masterclass: DiGa - Entering the digital health space in Germany

Anchored by:

Laura Nelde
Senior Consultant
FLYING HEALTH
Len Ortlepp
Studentische Hilfskraft
TECHNISCHE UNIVERSIT�T BERLIN

Participants:

Laura Nelde Senior ConsultantFlying Health
Laura Nelde
Senior ConsultantFlying Health
Len Ortlepp Studentische HilfskraftTechnische Universit�t Berlin
Len Ortlepp
Studentische HilfskraftTechnische Universit�t Berlin
Aahuti Rai NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Aahuti Rai
NED, Advisor & Venture PartnerFour Points Health | Conduit Connect
Benjamin D'hont Head strategic marketingVoluntis
Benjamin D'hont
Head strategic marketingVoluntis
Bernhard Kappe Founder & CEOOrthogonal
Bernhard Kappe
Founder & CEOOrthogonal
Dr. Nick (Nemanja) Kovacev Head of Healthcare and Life Sciences PracticeHTEC Group
Dr. Nick (Nemanja) Kovacev
Head of Healthcare and Life Sciences PracticeHTEC Group
Jyri Yli-Villamo Head of Pharma Global Strategic PartnershipsKaiku Health
Jyri Yli-Villamo
Head of Pharma Global Strategic PartnershipsKaiku Health
KF
Kunio Fujimoto Senior Manager Regulatory Affairs in DTxEISAI
KF
Kunio Fujimoto
Senior Manager Regulatory Affairs in DTxEISAI
Kyloon Chuah Co-Founder, Chief Product & Tech OfficerVeriteos
Kyloon Chuah
Co-Founder, Chief Product & Tech OfficerVeriteos
Laura Lang Medical Science ManagerKaiku Health
Laura Lang
Medical Science ManagerKaiku Health
Lina Behrens Head of Strategy & Content, Director HTSHLTH Europe
Lina Behrens
Head of Strategy & Content, Director HTSHLTH Europe
Natalie Principe Member Board of Directors and Management TeamActual Healthcare Solutions
Natalie Principe
Member Board of Directors and Management TeamActual Healthcare Solutions
Todd Greenwood Director Evidence GenerationZS Associates
Todd Greenwood
Director Evidence GenerationZS Associates

About this Meeting

The right commercialization model for a digital therapeutic (DTx) product is a key component of success in this rapidly growing space. However, whether you choose a pharma partnership or another popular distribution channel, success is likely to depend on physician awareness of your DTx and their willingness to prescribe or recommend it. Germany’s  Digital Healthcare Act (DVG) and the Digital Health Applications Ordinance (DiGAV) have the potential to play a key role in not only providing a path to reimbursement for digital health applications including DTx, but also for increasing provider awareness and trust in digital therapies. Apps that are approved for the DiGA directory become reimbursable under the German statutory health insurance, making them prescribable to approximately 72.8 million people.  

 But what do you need to know to navigate the DiGa framework? Join us in this interactive masterclass led by Flying Health, who will walk us through:  

  •  General overview and current landscape: what DiGa is and what it’s not, why it is an opportunity for digital health companies in the EU market, digital health tools approved so far, average price and current prescription & adoption rates. 
  •  How to apply, requirements and keys to succeed: what products are eligible to apply, evidence needed, pricing, data security, UX, interoperability, reporting significant changes in the product, etc.  
  •  Once you have your DiGa approved, what else do you need to do to ensure a high number of prescriptions and patient adoption?